Myoview

— THERAPEUTIC CATEGORIES —
  • Imaging agents

Myoview Generic Name & Formulations

General Description

Technetium Tc99m tetrofosmin 0.23mg; lyophilized pwd for IV inj after radiolabeling; preservative-free.

Pharmacological Class

Radioactive diagnostic agent.

How Supplied

Kit—5 (multi-dose vials)

Manufacturer

Generic Availability

NO

Mechanism of Action

Technetium (99mTc) tetrofosmin is a lipophilic, cationic complex which diffuses passively through the cell membrane and is locally retained actively due to the presence of intact mitochondria reflecting the presence of viable cells. After IV injection, it is distributed within the myocardium according to myocardial perfusion and viability.

Myoview Indications

Indications

Myocardial perfusion imaging under rest and/or exercise or pharmacologic stress conditions to delineate regions of reversible myocardial ischemia or infarcted myocardium in patients with known or suspected coronary artery disease. For assessment of left ventricular function (LVEF and wall motion) in patients with known or suspected heart disease.

Myoview Dosage and Administration

Adult

See full labeling. Rest and stress imaging: give 185–1,221MBq (5–33mCi) as IV inj. When rest and stress IV inj (given on the same day): initially 185–444MBq (5–12mCi), followed by 555–1,221MBq (15–33mCi) given ~1–4hrs after. Ventricular function imaging: give 185–1,221MBq (5–33mCi) as IV inj. 

Children

Not established.

Myoview Contraindications

Not Applicable

Myoview Boxed Warnings

Not Applicable

Myoview Warnings/Precautions

Warnings/Precautions

Have cardiopulmonary resuscitation equipment readily available. Risk for radiation exposure. Should only be used by trained and experienced physicians in the safe use and handling of radioactive materials to minimize radiation exposure. Ensure adequate hydration. Advise to void after exam, and frequently thereafter. Monitor for hypersensitivity reactions. Pregnancy. Nursing mothers: pump and discard breast milk for 60hrs after administration. 

Myoview Pharmacokinetics

Elimination

Renal (~40%), fecal (~26%). 

Myoview Interactions

Not Applicable

Myoview Adverse Reactions

Adverse Reactions

Angina, hypertension, torsades de pointes, vomiting, abdominal discomfort, cutaneous allergy, hypotension, dyspnea, metallic taste, burning of the mouth, smell alteration. 

Myoview Clinical Trials

See Literature

Myoview Note

Not Applicable

Myoview Patient Counseling

See Literature